Results from a phase 1 multiple ascending dose study demonstrating safety and selectivity of aldosterone synthase inhibitor CIN-107
26 August 2022 (08:00 - 19:30)
Organised by:
About the speaker
CinCor Pharma, Boston (United States of America)
7 More presentations in this session
Associate Professor A. Attar (Shiraz, IR)
Doctor M. Sadulloeva (Tashkent, UZ)
Professor D. Bertolim Precoma (Campina Grande do Sul, BR)
Doctor F. Goetzinger (Basel, CH)
Access the full session
The Event
ESC Congress 2022
26 August - 29 August 2022
You may be interested in
Congress Presentation
